Trial Profile
A study of irbesartan/amlodipine on hypertensive patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2015
Price :
$35
*
At a glance
- Drugs Amlodipine/irbesartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms AIMIX
- 07 Sep 2015 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan record.
- 05 Jun 2015 New trial record